| Literature DB >> 10984308 |
R Burvin1, D LeRoith, H Harel, M Zloczower, M Marbach, E Karnieli.
Abstract
The in vivo effects of the insulin-like growth factor-II (IGF-II) on glucose metabolism is not yet well defined. To assess the acute effect of IGF-II administration on whole body glucose utilization and hepatic glucose production, we used the well-established euglycemic clamp technique and compared the effects in awake cannulated rats with those of insulin. Each animal underwent several 90-min euglycemic studies, alternating between IGF-II and insulin. Following IGF-II infusion, tissue glucose uptake was increased to 9.8 +/- 0.6 mg/kg/min (mean +/- SEM), which represented only 14% of the effect of insulin, despite the molar plasma concentration ratio of insulin: IGF-2 being 1:460. IGF-II and insulin infusion reduced hepatic glucose output by 49 and 75%, respectively. Thus, IGF-II, administered acutely, affects glucose homeostasis in a manner very similar to insulin, probably via the insulin receptors, although with significantly lower potency.Entities:
Mesh:
Substances:
Year: 1998 PMID: 10984308 DOI: 10.1016/s1096-6374(98)80112-3
Source DB: PubMed Journal: Growth Horm IGF Res ISSN: 1096-6374 Impact factor: 2.372